Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 842

1.

Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE).

Coleman CN, Bader JL, Koerner JF, Hrdina C, Cliffer KD, Hick JL, James JJ, Mansoura MK, Livinski AA, Nystrom SV, DiCarlo-Cohen A, Marinissen MJ, Wathen L, Appler JM, Buddemeier B, Casagrande R, Estes D, Byrne P, Kennedy EM, Jakubowski AA, Case C, Weinstock DM, Dainiak N, Hanfling D, Garrett AL, Grant NN, Dodgen D, Redlener I, MacKAY TF, Treber M, Homer MJ, Taylor TP, Miller A, Korch G, Hatchett R.

Disaster Med Public Health Prep. 2019 Jun 17:1-16. doi: 10.1017/dmp.2018.163. [Epub ahead of print]

PMID:
31203830
2.

Non-modifiable Risk Factors Associated with Avascular Necrosis in the US Military.

Gun BK, Frank RM, Gratton RW, Bader JO, Kusnezov N, Orr JD, Waterman BR.

Mil Med. 2019 Jun 11. pii: usz128. doi: 10.1093/milmed/usz128. [Epub ahead of print]

PMID:
31184698
3.

Cortical circuit alterations precede motor impairments in Huntington's disease mice.

Burgold J, Schulz-Trieglaff EK, Voelkl K, Gutiérrez-Ángel S, Bader JM, Hosp F, Mann M, Arzberger T, Klein R, Liebscher S, Dudanova I.

Sci Rep. 2019 Apr 29;9(1):6634. doi: 10.1038/s41598-019-43024-w.

4.

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.

Bader JC, Lakota EA, Dale GE, Sader HS, Rex JH, Ambrose PG, Bhavnani SM.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00318-19. doi: 10.1128/AAC.00318-19. Print 2019 Jun.

PMID:
30962339
5.

Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia.

Bhavnani SM, Zhang L, Hammel JP, Rubino CM, Bader JC, Sader HS, Gelone SP, Wicha WW, Ambrose PG.

J Antimicrob Chemother. 2019 Apr 1;74(Supplement_3):iii35-iii41. doi: 10.1093/jac/dkz089.

6.

Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence.

Dutta NK, Klinkenberg LG, Vazquez MJ, Segura-Carro D, Colmenarejo G, Ramon F, Rodriguez-Miquel B, Mata-Cantero L, Porras-De Francisco E, Chuang YM, Rubin H, Lee JJ, Eoh H, Bader JS, Perez-Herran E, Mendoza-Losana A, Karakousis PC.

Sci Adv. 2019 Mar 20;5(3):eaav2104. doi: 10.1126/sciadv.aav2104. eCollection 2019 Mar.

7.

Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota.

Sougiannis AT, VanderVeen BN, Enos RT, Velazquez KT, Bader JE, Carson M, Chatzistamou I, Walla M, Pena MM, Kubinak JL, Nagarkatti M, Carson JA, Murphy EA.

Brain Behav Immun. 2019 Feb 23. pii: S0889-1591(18)31227-3. doi: 10.1016/j.bbi.2019.02.020. [Epub ahead of print]

PMID:
30807838
8.

A metabolic switch in proteasome inhibitor resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis.

Besse L, Besse A, Mendez-Lopez M, Vasickova K, Sedlackova M, Vanhara P, Kraus M, Bader J, Ferreira RB, Castellano RK, Law BK, Driessen C.

Haematologica. 2019 Feb 21. pii: haematol.2018.207704. doi: 10.3324/haematol.2018.207704. [Epub ahead of print]

9.

Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity.

Li L, Knutsdottir H, Hui K, Weiss MJ, He J, Philosophe B, Cameron AM, Wolfgang CL, Pawlik TM, Ghiaur G, Ewald AJ, Mezey E, Bader JS, Selaru FM.

JCI Insight. 2019 Jan 24;4(2). pii: 121490. doi: 10.1172/jci.insight.121490. [Epub ahead of print]

10.

Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors.

Besse A, Besse L, Kraus M, Mendez-Lopez M, Bader J, Xin BT, de Bruin G, Maurits E, Overkleeft HS, Driessen C.

Cell Chem Biol. 2019 Mar 21;26(3):340-351.e3. doi: 10.1016/j.chembiol.2018.11.007. Epub 2019 Jan 3.

PMID:
30612952
11.

Time for Precision: A World Without Susceptibility Breakpoints.

Bader JC, Lakota EA, Andes DR, Rubino CM, Ambrose PG, Bhavnani SM.

Open Forum Infect Dis. 2018 Oct 31;5(12):ofy282. doi: 10.1093/ofid/ofy282. eCollection 2018 Dec.

12.

Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments.

Bader JE, Enos RT, Velázquez KT, Carson MS, Sougiannis AT, McGuinness OP, Robinson CM, Murphy EA.

Am J Physiol Endocrinol Metab. 2019 Mar 1;316(3):E358-E372. doi: 10.1152/ajpendo.00438.2018. Epub 2018 Dec 21.

PMID:
30576244
13.

Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae.

Lepak AJ, Zhao M, Liu Q, Wang P, Wang Y, Bader JC, Ambrose PG, Andes DR.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02404-18. doi: 10.1128/AAC.02404-18. Print 2019 Mar.

PMID:
30559140
14.

Genome analysis of Mycobacterium avium subspecies hominissuis strain 109.

Matern WM, Bader JS, Karakousis PC.

Sci Data. 2018 Dec 4;5:180277. doi: 10.1038/sdata.2018.277.

15.

Traumatic Divergent Elbow Dislocation with Associated Forearm Amputation in an Adult: A Case Report.

Greene RM, Bader JE, Mauter L, Sears BW, Tirre CJ, Hatzidakis AM.

JBJS Case Connect. 2018 Oct-Dec;8(4):e92-5. doi: 10.2106/JBJS.CC.17.00252.

PMID:
30489376
16.

Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity.

Hartmann H, Hornburg D, Czuppa M, Bader J, Michaelsen M, Farny D, Arzberger T, Mann M, Meissner F, Edbauer D.

Life Sci Alliance. 2018 May 16;1(2):e201800070. doi: 10.26508/lsa.201800070. eCollection 2018 May.

17.

Effects of high fat diet-induced obesity on mammary tumorigenesis in the PyMT/MMTV murine model.

Cranford TL, Velázquez KT, Enos RT, Sougiannis AT, Bader JE, Carson MS, Bellone RR, Chatzistamou I, Nagarkatti M, Murphy EA.

Cancer Biol Ther. 2019;20(4):487-496. doi: 10.1080/15384047.2018.1537574. Epub 2018 Nov 2.

PMID:
30388923
18.

Alpha-Amino-Beta-Carboxy-Muconate-Semialdehyde Decarboxylase Controls Dietary Niacin Requirements for NAD+ Synthesis.

Palzer L, Bader JJ, Angel F, Witzel M, Blaser S, McNeil A, Wandersee MK, Leu NA, Lengner CJ, Cho CE, Welch KD, Kirkland JB, Meyer RG, Meyer-Ficca ML.

Cell Rep. 2018 Oct 30;25(5):1359-1370.e4. doi: 10.1016/j.celrep.2018.09.091.

19.

Femoral Hernias: Analysis of Preoperative Risk Factors and 30-Day Outcomes of Initial Groin Hernias Using ACS-NSQIP.

Halgas B, Viera J, Dilday J, Bader J, Holt D.

Am Surg. 2018 Sep 1;84(9):1455-1461.

PMID:
30268175
20.

Guidance, Training and Exercises for Responding to an Improvised Nuclear Device: First Receivers, Public Health.

Case C Jr, Coleman CN, Bader JL, Hick J, Hanfling D.

Health Phys. 2018 Feb;114(2):165-172. doi: 10.1097/HP.0000000000000759.

PMID:
30086007
21.

Predictors of Acute Complications Following Traumatic Upper Extremity Amputation.

Fisher TF, Kusnezov NA, Bader JA, Blair JA.

J Surg Orthop Adv. Summer 2018;27(2):113-118.

PMID:
30084818
22.

PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity.

van Setten J, Brody JA, Jamshidi Y, Swenson BR, Butler AM, Campbell H, Del Greco FM, Evans DS, Gibson Q, Gudbjartsson DF, Kerr KF, Krijthe BP, Lyytikäinen LP, Müller C, Müller-Nurasyid M, Nolte IM, Padmanabhan S, Ritchie MD, Robino A, Smith AV, Steri M, Tanaka T, Teumer A, Trompet S, Ulivi S, Verweij N, Yin X, Arnar DO, Asselbergs FW, Bader JS, Barnard J, Bis J, Blankenberg S, Boerwinkle E, Bradford Y, Buckley BM, Chung MK, Crawford D, den Hoed M, Denny JC, Dominiczak AF, Ehret GB, Eijgelsheim M, Ellinor PT, Felix SB, Franco OH, Franke L, Harris TB, Holm H, Ilaria G, Iorio A, Kähönen M, Kolcic I, Kors JA, Lakatta EG, Launer LJ, Lin H, Lin HJ, Loos RJF, Lubitz SA, Macfarlane PW, Magnani JW, Leach IM, Meitinger T, Mitchell BD, Munzel T, Papanicolaou GJ, Peters A, Pfeufer A, Pramstaller PP, Raitakari OT, Rotter JI, Rudan I, Samani NJ, Schlessinger D, Silva Aldana CT, Sinner MF, Smith JD, Snieder H, Soliman EZ, Spector TD, Stott DJ, Strauch K, Tarasov KV, Thorsteinsdottir U, Uitterlinden AG, Van Wagoner DR, Völker U, Völzke H, Waldenberger M, Jan Westra H, Wild PS, Zeller T, Alonso A, Avery CL, Bandinelli S, Benjamin EJ, Cucca F, Dörr M, Ferrucci L, Gasparini P, Gudnason V, Hayward C, Heckbert SR, Hicks AA, Jukema JW, Kääb S, Lehtimäki T, Liu Y, Munroe PB, Parsa A, Polasek O, Psaty BM, Roden DM, Schnabel RB, Sinagra G, Stefansson K, Stricker BH, van der Harst P, van Duijn CM, Wilson JF, Gharib SA, de Bakker PIW, Isaacs A, Arking DE, Sotoodehnia N.

Nat Commun. 2018 Jul 25;9(1):2904. doi: 10.1038/s41467-018-04766-9.

23.

Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.

Graham JC, Wilt N, Costin GE, Villano C, Bader J, Krawiec L, Sly E, Gould J.

Cutan Ocul Toxicol. 2018 Dec;37(4):380-390. doi: 10.1080/15569527.2018.1483944. Epub 2018 Jul 23.

PMID:
30035615
24.

Proposed "Exposure And Symptom Triage" (EAST) Tool to Assess Radiation Exposure After a Nuclear Detonation.

Hick JL, Bader JL, Coleman CN, Ansari AJ, Chang A, Salame-Alfie A, Hanfling D, Koerner JF.

Disaster Med Public Health Prep. 2018 Jun;12(3):386-395. doi: 10.1017/dmp.2017.86. Epub 2017 Jul 31.

PMID:
29911522
25.

Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Woodham AW, Cheloha RW, Ling J, Rashidian M, Kolifrath SC, Mesyngier M, Duarte JN, Bader JM, Skeate JG, Da Silva DM, Kast WM, Ploegh HL.

Cancer Immunol Res. 2018 Jul;6(7):870-880. doi: 10.1158/2326-6066.CIR-17-0661. Epub 2018 May 23.

PMID:
29792298
26.

Heterozygous diploid and interspecies SCRaMbLEing.

Shen MJ, Wu Y, Yang K, Li Y, Xu H, Zhang H, Li BZ, Li X, Xiao WH, Zhou X, Mitchell LA, Bader JS, Yuan Y, Boeke JD.

Nat Commun. 2018 May 22;9(1):1934. doi: 10.1038/s41467-018-04157-0.

27.

Determination of Proper Timing for the Placement of Intra-Abdominal Mesh after Incidental Enterotomy in a Rodent Model (Rattus norvegicus).

Muir KB, Smoot CP, Viera JL, Sirkin MR, Yoon B, Bader J, Smiley R, Holt D, Hofmann LJ.

Am Surg. 2018 Apr 1;84(4):593-598.

PMID:
29712612
28.

Gene Enrichment Analysis Reveals Major Regulators of Mycobacterium tuberculosis Gene Expression in Two Models of Antibiotic Tolerance.

Matern WM, Rifat D, Bader JS, Karakousis PC.

Front Microbiol. 2018 Apr 4;9:610. doi: 10.3389/fmicb.2018.00610. eCollection 2018.

29.

A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors.

Venkataraman A, Yang K, Irizarry J, Mackiewicz M, Mita P, Kuang Z, Xue L, Ghosh D, Liu S, Ramos P, Hu S, Bayron Kain D, Keegan S, Saul R, Colantonio S, Zhang H, Behn FP, Song G, Albino E, Asencio L, Ramos L, Lugo L, Morell G, Rivera J, Ruiz K, Almodovar R, Nazario L, Murphy K, Vargas I, Rivera-Pacheco ZA, Rosa C, Vargas M, McDade J, Clark BS, Yoo S, Khambadkone SG, de Melo J, Stevanovic M, Jiang L, Li Y, Yap WY, Jones B, Tandon A, Campbell E, Montelione GT, Anderson S, Myers RM, Boeke JD, Fenyö D, Whiteley G, Bader JS, Pino I, Eichinger DJ, Zhu H, Blackshaw S.

Nat Methods. 2018 May;15(5):330-338. doi: 10.1038/nmeth.4632. Epub 2018 Mar 19.

30.

Tonometry.

Bader J, Havens SJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 5.

31.

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata.

Bader JC, Lakota EA, Flanagan S, Ong V, Sandison T, Rubino CM, Bhavnani SM, Ambrose PG.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02614-17. doi: 10.1128/AAC.02614-17. Print 2018 Jun.

32.

Exploration of spatial patterns of congenital anomalies in Los Angeles County using the vital statistics birth master file.

Rible R, Aguilar E, Chen A, Bader JL, Goodyear-Moya L, Singh KT, Paulson SE, Friedman J, Izadpanah N, Pregler J.

Environ Monit Assess. 2018 Mar 2;190(4):184. doi: 10.1007/s10661-018-6539-0.

PMID:
29500732
33.

Activation of Acetonitrile with (C2 F5 )3 PF2 and Amines.

Bader J, Neumann B, Stammler HG, Ignat'ev N, Hoge B.

Chemistry. 2018 May 11;24(27):6975-6982. doi: 10.1002/chem.201800682. Epub 2018 Mar 22.

PMID:
29488665
34.

Influence of 2 caries-detecting devices on clinical decision making and lesion depth for suspicious occlusal lesions: A randomized trial from The National Dental Practice-Based Research Network.

Makhija SK, Bader JD, Shugars DA, Litaker MS, Nagarkar S, Gordan VV, Rindal DB, Pihlstrom DJ, Mungia R, Meyerowitz C, Gilbert GH; National Dental Practice-Based Research Network (PBRN) Collaborative Group.

J Am Dent Assoc. 2018 Apr;149(4):299-307.e1. doi: 10.1016/j.adaj.2017.11.001. Epub 2018 Feb 21.

35.

Correction to: PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside.

Bulik CC, Bader JC, Zhang L, Van Wart SA, Rubino CM, Bhavnani SM, Sweeney KL, Ambrose PG.

J Pharmacokinet Pharmacodyn. 2018 Apr;45(2):351. doi: 10.1007/s10928-018-9572-2.

PMID:
29446052
36.

Phenotypic co-receptor tropism and Maraviroc sensitivity in HIV-1 subtype C from East Africa.

Siddik AB, Haas A, Rahman MS, Aralaguppe SG, Amogne W, Bader J, Klimkait T, Neogi U.

Sci Rep. 2018 Feb 5;8(1):2363. doi: 10.1038/s41598-018-20814-2.

37.

Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity.

Ambrose PG, VanScoy BD, Adams J, Fikes S, Bader JC, Bhavnani SM, Rubino CM.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02257-17. doi: 10.1128/AAC.02257-17. Print 2018 Apr.

38.

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.

Zhao M, Lepak AJ, VanScoy B, Bader JC, Marchillo K, Vanhecker J, Ambrose PG, Andes DR.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02542-17. doi: 10.1128/AAC.02542-17. Print 2018 Apr.

39.

Comparing clinician use of three ankle fracture classifications.

Cordova CB, Dunn JC, Kusnezov N, Bader JM, Waterman BR, Orr JD.

JAAPA. 2018 Feb;31(2):36-39. doi: 10.1097/01.JAA.0000529773.90897.9f.

PMID:
29369927
40.

We can do better: a fresh look at echinocandin dosing.

Bader JC, Bhavnani SM, Andes DR, Ambrose PG.

J Antimicrob Chemother. 2018 Mar 1;73(3):831. doi: 10.1093/jac/dky013. No abstract available.

PMID:
29340605
41.

Muscle activity during maximal isometric forearm rotation using a power grip.

Bader J, Boland MR, Greybe D, Nitz A, Uhl T, Pienkowski D.

J Biomech. 2018 Feb 8;68:24-32. doi: 10.1016/j.jbiomech.2017.12.011. Epub 2017 Dec 15.

PMID:
29305049
42.

We can do better: a fresh look at echinocandin dosing.

Bader JC, Bhavnani SM, Andes DR, Ambrose PG.

J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i44-i50. doi: 10.1093/jac/dkx448. Review. Erratum in: J Antimicrob Chemother. 2018 Mar 1;73(3):831.

PMID:
29304211
43.

Predictors of Persistent Pain After Fixation of Distal Clavicle Fractures in an Active Military Population.

Lanier PJ, Speirs J, Koehler L, Bader J, Abdelgawad A, Waterman BR.

Orthopedics. 2018 Jan 1;41(1):e117-e126. doi: 10.3928/01477447-20171127-02. Epub 2017 Dec 1.

PMID:
29192935
44.

Occupational outcomes following combat-related gunshot injury: Cohort study.

Laughlin MD, Belmont PJ Jr, Lanier PJ, Bader JO, Waterman BR, Schoenfeld AJ.

Int J Surg. 2017 Dec;48:286-290. doi: 10.1016/j.ijsu.2017.11.037. Epub 2017 Nov 27.

PMID:
29191407
45.

Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir.

Abt D, Besse A, Sedlarikova L, Kraus M, Bader J, Silzle T, Vodinska M, Slaby O, Schmid HP, Engeler DS, Driessen C, Besse L.

BJU Int. 2018 Apr;121(4):600-609. doi: 10.1111/bju.14083. Epub 2017 Dec 10.

46.

A systematic surveillance programme for infectious salmon anaemia virus supports its absence in the Pacific Northwest of the United States.

Gustafson LL, Creekmore LH, Snekvik KR, Ferguson JA, Warg JV, Blair M, Meyers TR, Stewart B, Warheit KI, Kerwin J, Goodwin AE, Rhodes LD, Whaley JE, Purcell MK, Bentz C, Shasa D, Bader J, Winton JR.

J Fish Dis. 2018 Feb;41(2):337-346. doi: 10.1111/jfd.12733. Epub 2017 Nov 21.

PMID:
29159889
47.

Ensuring quality pharmacokinetic analyses in antimicrobial drug development programs.

Lakota EA, Bader JC, Rubino CM.

Curr Opin Pharmacol. 2017 Oct;36:139-145. doi: 10.1016/j.coph.2017.10.014. Epub 2017 Nov 20. Review.

PMID:
29156443
48.

Relatively enriched housing conditions delay binge onset but do not attenuate binge size.

Preston KE, Corwin RL, Bader JO, Crimmins SL.

Physiol Behav. 2018 Feb 1;184:196-204. doi: 10.1016/j.physbeh.2017.11.018. Epub 2017 Nov 15.

PMID:
29155246
49.

Dentists' decision strategies for suspicious occlusal caries lesions in a National Dental PBRN study.

Makhija SK, Robinson ME, Bader JD, Shugars DA, Litaker MS, Im HR, Rindal DB, Pihlstrom DJ, Meyerowitz C, Gordan VV, Buchberg MK, Gilbert GH; National Dental PBRNCollaborative Group.

J Dent. 2018 Feb;69:83-87. doi: 10.1016/j.jdent.2017.11.004. Epub 2017 Nov 11.

50.

Surface characteristics and lesion depth and activity of suspicious occlusal carious lesions: Findings from The National Dental Practice-Based Research Network.

Makhija SK, Shugars DA, Gilbert GH, Litaker MS, Bader JD, Schaffer R, Gordan VV, Rindal DB, Pihlstrom DJ, Mungia R, Meyerowitz C; National Dental Practice-Based Research Network Collaborative Group.

J Am Dent Assoc. 2017 Dec;148(12):922-929. doi: 10.1016/j.adaj.2017.08.009. Epub 2017 Oct 18.

Supplemental Content

Support Center